Error loading player: No playable sources found
114076
WATCH NOW: Utilizing HiBiT Targeted Cell Killing Bioassays To Validate Cell Therapy and mAb-Mediated Immunotherapy Potency
Date
June 11, 2024
This product is not available for individual purchase, but it is available as part of the following products:
This technical Seminar will be available to watch on demand 24/7 during the Symposium. Click on this session to access the presentation video.
NOTE: If prompted to login to view the video, enter your CASSS member credentials.
Presented by: Promega Corporation
Speaker
Related Products
Plenary Session 7 - Streamlining AAV Vector-based Gene Therapy Development Through the Utilization of Manufacturing and Analytical Platform Approaches
Our ability to treat diseases previously untreatable through the delivery of adeno-associated virus (AAV)-based gene therapies has been a tremendous advancement in pharmaceutical development…
WATCH NOW: Limiting Off-Target Effects of CRISPR-Based Products- Guide RNA Sequencing by NGS
This technical Seminar will be available to watch on demand 24/7 during the Symposium. Click on this session to access the presentation video…
Plenary Session 1 - Genetic Modification Technologies for Cell-based Gene Therapies
In addition to the now well-known CAR T (chimeric antigen receptor T cells) and HSC (CD34+ hematopoietic stem cells) cell-based gene therapies, there are several other modes of gene modification as well as cell types already approved and on the horizon…
